Eric Nicolaï

Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy

Philippe Beauverger, Marie‐Laure Ozoux, Guillaume Bégis et al. · Cardiovascular Research · 2019 · 54 citations

Medicine, Cardiology, Pharmacology +17

Discovery and Development of 5-[(5<i>S</i>,9<i>R</i>)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1

Dominique Potin, Michèle Launay, Francoise Monatlik et al. · Journal of Medicinal Chemistry · 2006 · 51 citations · Full text

Medicine, Immunology, Pharmacology +17

G-Protein-Coupled Receptor Affinity Prediction Based on the Use of a Profiling Dataset:  QSAR Design, Synthesis, and Experimental Validation

Catherine Rolland, Rafael Gozalbes, Eric Nicolaï et al. · Journal of Medicinal Chemistry · 2005 · 36 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and structure-activity relationships of novel benzimidazole and imidazo[4,5-b]pyridine acid derivatives as thromboxane A2 receptor antagonists

Eric Nicolaï, J. GOYARD, Thierry Benchetrit et al. · Journal of Medicinal Chemistry · 1993 · 35 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Synthesis and SAR Studies of Novel Triazolopyrimidine Derivatives as Potent, Orally Active Angiotensin II Receptor Antagonists

Eric Nicolaï, G. CURE, J. GOYARD et al. · Journal of Medicinal Chemistry · 1994 · 29 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9